| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Geron Corp (GERN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 3 sells. GERN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.00M | $5.40M | - | |
| VP | 3.00M | $4.05M | - | |
| VP | 2.50M | $3.38M | - | |
| Dir | 270.0K | $364.5K | - | |
| Dir | 220.0K | $297.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 29, 2015 | Bloom Olivia Kyusuk | EVP, Chief Financial Officer | Sell | 2,380 | $3.84 | $9,139.20 | -3.1% | |
| May 29, 2015 | Behrs Melissa Kelly | EVP Bd And Port&Alliance Mgmt | Sell | 2,380 | $3.84 | $9,139.20 | -1.9% | |
| Mar 18, 2015 | Hofstaetter Thomas | Director | Sale+OE | 70,000 | $4.10 | $287,000.00 | -72.5% |